Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zintl

Showing results (181-190 of 190) with videos related to

Pageof 19
Sort By:
You have reached the last page of results.This site can display upto 190 results.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Kinderarztliche Praxis|October 1, 1980
[Acute lymphatic leukemia of childhood--therapy and results]F Zintl, W Plenert, H J Blau, et al.
Journal of Inherited Metabolic Disease|July 23, 2003
Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase geneJ Seidel, S Streck, K Bellstedt, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Bone Marrow Transplantation|April 3, 2007
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working PartiesC Uderzo, M Pillon, P Corti, et al.
Leukemia|April 1, 2005
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemiaA Yoshimi, P Bader, S Matthes-Martin, et al.
Leukemia|December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000A Möricke, M Zimmermann, A Reiter, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidityI M De Kleer, D M C Brinkman, A Ferster, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Pageof 19

Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Blood|May 29, 2000
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study GroupM Schrappe, A Reiter, W D Ludwig, et al.
Bone Marrow Transplantation|September 5, 2007
Relapse, not regimen-related toxicity, was the major cause of treatment failure in 11 children with Down syndrome undergoing haematopoietic stem cell transplantation for acute leukaemiaB Meissner, A Borkhardt, D Dilloo, et al.
Kinderarztliche Praxis|October 1, 1980
[Acute lymphatic leukemia of childhood--therapy and results]F Zintl, W Plenert, H J Blau, et al.
Journal of Inherited Metabolic Disease|July 23, 2003
Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase geneJ Seidel, S Streck, K Bellstedt, et al.
Blood|November 24, 1999
Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90A Reiter, M Schrappe, M Tiemann, et al.
Bone Marrow Transplantation|April 3, 2007
Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working PartiesC Uderzo, M Pillon, P Corti, et al.
Leukemia|April 1, 2005
Donor leukocyte infusion after hematopoietic stem cell transplantation in patients with juvenile myelomonocytic leukemiaA Yoshimi, P Bader, S Matthes-Martin, et al.
Leukemia|December 17, 2009
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000A Möricke, M Zimmermann, A Reiter, et al.
Annals of the Rheumatic Diseases|September 14, 2004
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidityI M De Kleer, D M C Brinkman, A Ferster, et al.
British Journal of Haematology|June 8, 2004
Haematopoetic stem cell transplantation for refractory autoimmune cytopeniaJ R Passweg, M Rabusin, M Musso, et al.
Pageof 19